Skip to main content
SpringerLink
Log in

Ethylenediamine, profile of a sensitizing excipient

  • Review Articles
  • Published:
Pharmaceutisch Weekblad Aims and scope Submit manuscript

Abstract

Ethylenediamine is an excipient with many industrial and pharmaceutical uses. It is included in creams as a stabilizer and in aminophylline as the counter ion of theophylline. Ethylenediamine is one of the most frequent contact sensitizers, producing local and generalized reactions. Besides, many cases of systemically induced dermatitis have also been described both after oral, rectal and intravenous use. Inhalation of ethylenediamine or aminophylline dust may provoke rhinitis and asthmatic reactions. In contrast to these delayed reactions only one immediate reaction of the urticarial type after intravenous use has been described. Ethylenediamine shows cross-reactions with antihistamines of the ethylenediamine derivative group, with edetate, other amines, piperazine and hydroxyzine. Ethylenediamine shows a short half-life of about 0.55 h and a small volume of distribution of 0.133 l/kg. After oral administration its bioavailability is about 0.34, due to a substantial first-pass effect. Renal excretion of the unchanged substance amounts to only about 18% after intravenous and 3% after oral administration. It behaves independently from theophylline after administration of aminophylline. Good alternatives are now available for the pharmaceutical applications of ethylenediamine. Theophylline itself is well absorbed orally; for the intravenous administration theN-methylglucamine salt is sufficiently soluble. Suppositories containing pure theophylline are commercially available in some countries, but the experience with this product is relatively small.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Elias JA, Levinson I. Hypersensitivity reactions to aminophylline. Am Rev Respir Dis 1981;123:550–2.

    PubMed  Google Scholar 

  2. Cotgreave IA, Caldwell J. Comparative plasma pharmacokinetics of theophylline and ethylenediamine after administration of aminophylline to man. J Pharm Pharmacol 1983;35:378–82.

    PubMed  Google Scholar 

  3. Turner A, Osol A. The spectrophotometric determination of the dissociation of theophylline. J Am Pharm Assoc [Sci] 1949;38:158.

    Google Scholar 

  4. Yevstratova KI, Ivanova AI. Dissociation constants and methods for analyses of some organic bases. (In Russian.) Farmaciya 1968;17:41.

    Google Scholar 

  5. Cotgreave IA, Caldwell J. Physicochemical andin vitro biological studies on the possible association between theophylline and ethylenediamine in solution. J Pharm Pharmacol 1983;35:774–9.

    PubMed  Google Scholar 

  6. Tashma Z. NMR study of theophylline-ethylenediamine interactions in aqueous solution. J Pharm Pharmacol 1984;36:758–60.

    PubMed  Google Scholar 

  7. Zuidema J. Physical and chemical properties of xanthine derivatives. In: Merkus FWHM, Hendeles L, eds. Sustained release theophylline. Amsterdam: Excerpta Medica, 1983:11–27.

    Google Scholar 

  8. White MI, Douglas WS, Main RA. Contact dermatitis attributed to ethylenediamine. Br Med J 1978;1:415–6.

    PubMed  Google Scholar 

  9. Eriksen KE. Allergy to ethylenediamine. Arch Dermatol 1975;111:791.

    Article  Google Scholar 

  10. Tas J, Weissberg D. Allergy to aminophylline. Acta Allergol 1958;12:39–42.

    PubMed  Google Scholar 

  11. Baer RL, Cohen HJ, Neidorff AH. Allergic eczematous sensitivity to aminophylline. Arch Dermatol 1959;79:647–8.

    Google Scholar 

  12. Eberhartiger C. Kontaktallergie gegen äthylendiamin. Hautarzt 1964;15:450–1.

    PubMed  Google Scholar 

  13. Epstein E, Maibach HJ. Ethylenediamine. Arch Dermatol 1968;98:476–7.

    Article  PubMed  Google Scholar 

  14. Hjorth N. Dermatitis from ethylenediamine. Contact Dermatitis Newsletter 1969;5:107.

    Google Scholar 

  15. Maibach H, Epstein E. Ethylenediamine sensitivity. Contact Dermatitis Newsletter 1971;9:207.

    Google Scholar 

  16. Fisher AA. The broad implications of allergic sensitization to ethylenediamine hydrochloride. Contact Dermatitis Newsletter 1973;14:418–23.

    Google Scholar 

  17. Cronin E. Contact dermatitis. Edinburgh: Churchill Livingstone, 1980.

    Google Scholar 

  18. Dooms-Goossens A. Allergic contact dermatitis to ingredients used in topically applied pharmaceutical products and cosmetics. Leuven: Catholic University of Leuven, 1982. Dissertation.

    Google Scholar 

  19. Fisher AA. Ethylenediamine dermatitis. Arch Dermatol 1969;100:519–20.

    Article  PubMed  Google Scholar 

  20. Van Hecke E. Ethylenediamine sensitivity from exposure to epoxy resin hardeners and MycologsR cream. Contact Dermatitis 1975;1:344–8.

    PubMed  Google Scholar 

  21. Provost TT, Jillson OF. Ethylenediamine contact dermatitis. Arch Dermatol 1967;96:231–4.

    Article  PubMed  Google Scholar 

  22. Fisher AA. Contact dermatitis. Philadelphia: Lea and Febiger, 1973.

    Google Scholar 

  23. De Shazo RD, Stevenson HC. Generalized dermatitis to aminophylline. Ann Allergy 1981:46:152–5.

    PubMed  Google Scholar 

  24. Hardy C, Schofield O, George CF. Allergy to aminophylline. Br Med J 1983;286:2051–2.

    Google Scholar 

  25. Petrozzi JW, Shore RN. Generalized exfoliative dermatitis from ethylenediamine. Arch Dermatol 1976;112:525–6.

    Article  PubMed  Google Scholar 

  26. Bernstein JE, Lorincz AL. Ethylenediamine-induced exfoliative erythroderma. Arch Dermatol 1979;115:360–1.

    Article  PubMed  Google Scholar 

  27. Van den Berg WHHW, Van Ketel WG. Contactallergie voor ethyleendiamine. Ned Tijdschr Geneeskd 1983;127:1801–2.

    PubMed  Google Scholar 

  28. Lawyer CH, Bardana EJ, Rodgers R, Gerber N. Utilization of intravenous dihydroxypropyltheophylline in an aminophylline-sensitive patient, and its pharmacokinetic comparison with theophylline. J Allergy Clin Immunol 1980;65:353–7.

    Article  PubMed  Google Scholar 

  29. Booth BH, Coleman WP, Mitchell DQ. Urticaria following intravenous aminophylline. Ann Allergy 1979;43:289–90.

    PubMed  Google Scholar 

  30. Lam S, Chan-Yeung M. Ethylenediamine-induced asthma. Am Rev Respir Dis 1980;121:151–5.

    PubMed  Google Scholar 

  31. Fisher AA. Allergic paraben and benzylalcohol hypersensitivity relationship of the ‘delayed’ and ‘immediate’ varieties. Contact Dermatitis 1975;1:281–4.

    PubMed  Google Scholar 

  32. Wong D, Lopapa AF, Haddad ZH. Immediate hypersensitivity reaction to aminophylline. J Allergy Clin Immunol 1971;48:165–70.

    Article  PubMed  Google Scholar 

  33. Fisher AA. Instructions for the ethylenediamine-sensitive patient. Cutis 1974;13:27–8.

    Google Scholar 

  34. White MI. Contact Dermatitis from ethylenediamine. Contact Dermatitis 1978;4:291–3.

    PubMed  Google Scholar 

  35. Calnan CD. Occupational piperazine Dermatitis. Contact Dermatitis 1975;1:126.

    Google Scholar 

  36. Burry JN. Ethylenediamine sensitivity with a systemic reaction to piperazine citrate. Contact Dermatitis 1978;4:380.

    PubMed  Google Scholar 

  37. Wright S, Harman RRH. Ethylenediamine and piperazine sensitivity. Br Med J 1983;287:463–4.

    Google Scholar 

  38. Rudzki E, Krajenska D. Cross-reactions between ethylenediamine, diethylenetriamine and triethylenetetramine. Contact Dermatitis 1976;2:311–3.

    PubMed  Google Scholar 

  39. Epstein E. Negative patchtests to ethylenediaminetetra-acetate in patients allergie to ethylenediamine. Contact Dermatitis Newsletter 1974;16:475.

    Google Scholar 

  40. Raymond JZ, Gross PR. EDTA: preservative dermatitis. Arch Dermatol 1969;100:436.

    Article  PubMed  Google Scholar 

  41. Caldwell J, Cotgreave IA. Comparative disposition of theophylline and ethylenediamine given as aminophylline to human volunteers. Br J Clin Pharmacol 1982;14:610 P.

    Google Scholar 

  42. Caldwell J, Cotgreave IA. Verteilung von Theophyllin and Ethylendiamin verabreicht als Theophyllin-Ethylendiamin bei Probanden. Therapiewoche 1983;33:969–76.

    Google Scholar 

  43. Caldwell J, Cotgreave IA. An HPLC assay for ethylenediamine in plasma and urine. Br J Pharmacol 1982;77:419P.

    Google Scholar 

  44. Caldwell J, Cotgreave IA. The metabolism of ethylenediamine in the rat. Br J Pharmacol 1983;78:62 P.

    Google Scholar 

  45. Markiw RT. Isolation ofN-acetylethylenediamine from urine of patients on Amesec. Biochem Med 1975;14:152–5.

    Article  PubMed  Google Scholar 

  46. McGinity JW, Brown RL. Stabilizing effect of inorganic phosphate salts on antibiotic-steroid ophthalmic preparations. J Pharm Sci 1975;64:1528–30.

    PubMed  Google Scholar 

  47. Bülow KB, Larsson H, Leideman T. Plasma level and broncholytic effect of choline theophyllinate after a single dose of a press-coated tablet formulation. Eur J Clin Pharmacol 1975;8:115–8.

    Article  PubMed  Google Scholar 

  48. Jonkman JHG, Holtkamp-Zieleman MB, Hoff-van den Berg EM, Grimberg N, Schoenmaker R. Oploskarakteristieken van enkele cholinetheofyllinaattabletten. Pharm Weekbl 1981;116:665–71.

    Google Scholar 

  49. Curtis GH, Crawford PF. Cutaneous sensitivity to monoglycerol para-aminobenzoate. Cleve Clin Q 1951;35–40.

  50. Martindale. The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982.

    Google Scholar 

  51. Zuidema J, Merkus FWHM. Chemical and biopharmaceutical aspects of theophylline and its derivatives. Curr Med Res Opin 1979;6:14S-25S.

    Google Scholar 

  52. French IW, Mildon CA. The pharmacokinetics of theophylline. Curr Med Res Opin 1979;6:3S-13S.

    Google Scholar 

  53. Tukker JJ, De Blaey CJ. Prolonged storage of aminophylline suppositories. Pharm Weekbl [Sci] 1984;6:96–8.

    Google Scholar 

  54. FNA. Formulary of the Dutch Pharmacists. The Hague: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, 1979.

    Google Scholar 

  55. Zuidema J, Merkus FWHM. Pharmacokinetics and pharmacodynamics of diprophylline. Pharm Weekbl [Sci] 1981;3:216–21.

    Google Scholar 

  56. Monks TJ, Smith RL, Caldwell J. A metabolic and pharmacokinetic comparison of theophylline and aminophylline. J Pharm Pharmacol 1981;33:93–7.

    PubMed  Google Scholar 

  57. Caldwell J, Monks TJ, Smith RL. A comparison of the metabolism and pharmacokinetics of intravenously administered theophylline and aminophylline in man. Br J Pharmacol 1978;63:369P-70P.

    Google Scholar 

  58. Caldwell J, Cotgreave IA. Plasma protein binding and distribution in the blood of theophylline and aminophylline. Br J Pharmacol 1981;74:876–7P.

    Google Scholar 

  59. Aslaksen A, Bakke OM, Vigander T. Comparative pharmacokinetics of theophylline and aminophylline in man. Br J Clin Pharmacol 1981;11:269–73.

    PubMed  Google Scholar 

  60. Zimmerman I, Schulz HU, Ulmer WT. Blutspiegelverlauf bei intravenöser, intramuskulärer und oraler Gabe von Theophyllin-aethylendiamin und neutral gelöstem Theophyllin. Arzneim Forsch 1978;28:1652–4.

    Google Scholar 

  61. Baccouche M, Dittman EC, Eltze M, Kilian U. Ethylendiamine —Pharmakologie von Aethylendiamin und dessen Wechselwirkung mit Theophyllin. Prax Klin Pneumol 1983;37:322–5.

    PubMed  Google Scholar 

  62. Stone TW, Perkins MN. Ethylenediamine as a GABA-mimetic. TIPS 1984;241–3.

  63. Greif N. Cutaneous safety of fragrance material as measured by the maximization test. Am Perf and Cosm 1967;82:54–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biopharmaceutics, University of Amsterdam, Plantage Muidergracht 14, 1018, TV Amsterdam, The Netherlands

    J. Zuidema

Authors
  1. J. Zuidema
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zuidema, J. Ethylenediamine, profile of a sensitizing excipient. Pharmaceutisch Weekblad Scientific Edition 7, 134–140 (1985). https://doi.org/10.1007/BF02097249

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02097249

Keywords

Search

Navigation